WASHINGTON (MedPage Today) — The FDA issued follow-up warning letters to six unapproved oral morphine sulfate manufacturers with one message: be ready for when the enforcement discretion lifts.
Read more…
Patients who maintain a greater sense of purpose in life as they age may be protected against Alzheimer’s disease, researchers have found.
Read more…
The investigational Alzheimer’s disease drug latrepirdine (Dimebon) failed in the pivotal CONNECTION trial of patients with mild-to-moderate disease, the drug’s makers announced today.
Read more…
A new PET scan neuroimaging technique measured drug-related reductions in the size of brain plaques thought to be responsible for the progression of Alzheimer’s disease, a new study found.
Read more…
Marijuana use at a young age significantly increased the risk of psychosis in young adulthood, Australian investigators reported.
Read more…
Group cognitive behavioral therapy may help patients with chronic or acute low-back pain, British researchers say.
Read more…
In older individuals, hospitalization is associated with reduced cognitive function, researchers found.
Read more…
Exposure to antidepressants in the womb was associated with slightly delayed developmental milestones in the first 19 months of life, particularly for boys, researchers found.
Read more…
SAN FRANCISCO -– A potent capsaicin patch (Qutenza) recently approved to ease neuropathic pain from shingles burned hopes for similar efficacy in HIV-associated distal sensory polyneuropathy.
Read more…
Increases in alcohol-related fatalities among young women drivers have outpaced the decade-long rise in such deaths among young men, researchers found.
Read more…
